Paroxysmal Nocturnal Hemoglobinuria (PNH) - Ultomiris Drug Market Statistics
The global paroxysmal nocturnal hemoglobinuria (pnh) ultomiris drug market size was valued at US$ 3,924.0 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 28.5% from 2024 to 2030.
Related Statistics
No records
No related statistics found.
Ultomiris Drug Market Scope
Ultomiris drug market segmentation & scope
Atypical Hemolytic Uremic Syndrome (aHUS)
Generalized Myasthenia Gravis (gMG)
Neuromyelitis Optica Spectrum Disorder (NMOSD)
End Use
Adult
Pediatric
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Ultomiris Drug Market Outlook
- HTML
- PPT
- -
Everything on Ultomiris Drug Market Outlook in one document: edited and divided into chapters, including detailed references.
Related industry reports
Related Regional Reports
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
